We are live on ! Find out more
MGCD

MGC Diagnostics Corporation
MGCD

Delisted

MGCD was delisted on the 28th of December, 2017.

14 hedge funds and large institutions have $5.86M invested in MGC Diagnostics Corporation in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

8% more capital invested

Capital invested by funds: $5.44M → $5.86M (+$423K)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

7% less funds holding

Funds holding: 1514 (-1)

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

MGCD Hedge Fund Activity: Q2 2016 in Review

14 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in MGC Diagnostics Corporation (MGCD) for Q2 2016, worth a combined $5.86M — up 7.8% from $5.44M a quarter earlier.

Fund positioning in MGCD was balanced in Q2 2016: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $96.9K. The largest seller was UBS Group, cutting an estimated $10.6K.

  • 14 institutional investors held MGC Diagnostics Corporation (MGCD) as of Q2 2016, down from 15 in Q1 2016.
  • Funds reported $5.86M of MGC Diagnostics Corporation stock for Q2 2016, up 7.8% quarter-over-quarter.
  • 1 fund opened new MGC Diagnostics Corporation positions in Q2 2016 and 1 closed out, a net change of 0 holders.
  • The largest MGC Diagnostics Corporation buyer in Q2 2016 was Susquehanna International Group, an estimated $96.9K added.
  • The largest MGC Diagnostics Corporation seller in Q2 2016 was UBS Group, an estimated $10.6K sold.

Based on aggregated 13F filings for Q2 2016.